139264-69-0: Zolmitriptan Related Compound B

Zolmitriptan Related Compound B/Zolmitriptan Impurity 06(CAS No: 139264-69-0) or (S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol,Zolmitriptan Related Compound B is an impurity of Zolmitriptan, it is used for the acute treatment of migraine by an inhibition of pre-junctional receptors on perivascular afferent fibers of the trigeminal nerve

Additional information on CAS 139264-69-0

Catalogue No.

VL350007

CAS No.

139264-69-0

Molecular Formula

C₁₅H₂₃N₃O

Molecular Weight

261.37 g/mol

Parent drug

Zolmitriptan

IUPAC Name

(S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol

Synonyms

Zolmitriptan EP Impurity F; Zolmitriptan Descarbonyl; (?S)-?-Amino-3-[2-(dimethylamino)ethyl]-1H-indole-5-propanol; ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol; Zolmitriptan Related Compound A; Zolmitriptan USP Related Compound B

Smiles

CC(CC1=CC2=C(C=C1)NC=C2CCN(C)C)(N)O

References

A Review of the Pharmacokinetics, Pharmacodynamics and Efficacy of Zolmitriptan in the Acute Abortive Treatment of Migraine By A.A. Kalanuria, B.L. Peterlin Container: Clinical Medicine. Therapeutics Year: 2009 Volume: 1 DOI: 10.4137/cmt.s2056 URL: https://journals.sagepub.com/doi/full/10.4137/CMT.S2056

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

139264-69-0: Zolmitriptan Related Compound B

139264-69-0: Zolmitriptan Related Compound B
Catalogue No.

VL350007

CAS No.

139264-69-0

Molecular Formula

C₁₅H₂₃N₃O

Molecular Weight

261.37 g/mol

Parent drug

Zolmitriptan

IUPAC Name

(S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol

Synonyms

Zolmitriptan EP Impurity F; Zolmitriptan Descarbonyl; (?S)-?-Amino-3-[2-(dimethylamino)ethyl]-1H-indole-5-propanol; ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol; Zolmitriptan Related Compound A; Zolmitriptan USP Related Compound B

Smiles

CC(CC1=CC2=C(C=C1)NC=C2CCN(C)C)(N)O

References

A Review of the Pharmacokinetics, Pharmacodynamics and Efficacy of Zolmitriptan in the Acute Abortive Treatment of Migraine By A.A. Kalanuria, B.L. Peterlin Container: Clinical Medicine. Therapeutics Year: 2009 Volume: 1 DOI: 10.4137/cmt.s2056 URL: https://journals.sagepub.com/doi/full/10.4137/CMT.S2056

Status

In-stock

ListName

Zolmitriptan Related Compound B

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden